Health Products

Mint-Rosuvastatin (2014-08-27)

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type III
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberCompaniesBrand nameDosage formDIN, NPN, DIN-HIMStrength
140001A
Recalling Firm
Mint Pharmaceuticals Inc.
1093 Meyerside Drive, Unit #1
Mississauga
L5T 1J6
Ontario
CANADA
Marketing Authorization Holder
Mint Pharmaceuticals Inc.
1093 Meyerside Drive, Unit #1
Mississauga
L5T 1J6
Ontario
CANADA
A. Mint-RosuvastatinTabletDIN 0239783840 mg

Introduction

Recalled products
  1. Mint-Rosuvastatin

Reason

During a post-market stability testing, it was discovered that there was a failure at three month long-term stability station. The product was high out of specification for total impurities at the 15-month time point.

Depth of distribution

Wholesalers and Retailers in Ontario, Quebec, British Columbia, Alberta, Newfoundland and Labrador and Manitoba
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime